PubMed:7804005
Annnotations
CL-cell
| Id | Subject | Object | Predicate | Lexical cue | cl_id |
|---|---|---|---|---|---|
| T1 | 138-149 | Cell | denotes | tumour cell | http://purl.obolibrary.org/obo/CL:0001063 |
| T2 | 287-298 | Cell | denotes | tumour cell | http://purl.obolibrary.org/obo/CL:0001063 |
GlyCosmos6-Glycan-Motif-Image
| Id | Subject | Object | Predicate | Lexical cue | image |
|---|---|---|---|---|---|
| T1 | 16-19 | Glycan_Motif | denotes | GD1 | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G81983KG|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G24638PB |
| T3 | 932-935 | Glycan_Motif | denotes | GM2 | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G79389NT|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G61168WC |
| T5 | 946-950 | Glycan_Motif | denotes | GD1a | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G69277LC|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G46677TE |
| T7 | 956-960 | Glycan_Motif | denotes | GM1b | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G03277YI |
| T8 | 994-998 | Glycan_Motif | denotes | GM1b | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G03277YI |
| T9 | 1006-1010 | Glycan_Motif | denotes | Gm1b | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G03277YI |
| T10 | 1043-1046 | Glycan_Motif | denotes | GD1 | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G81983KG|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G24638PB |
| T12 | 1126-1130 | Glycan_Motif | denotes | GD1a | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G69277LC|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G46677TE |
| T14 | 1255-1278 | Glycan_Motif | denotes | N-acetylneuraminic acid | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G81533KY|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G50850NI |
| T16 | 1291-1302 | Glycan_Motif | denotes | sialic acid | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G81533KY |
Glycosmos6-GlycoEpitope
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 946-950 | http://www.glycoepitope.jp/epitopes/EP0056 | denotes | GD1a |
| T2 | 956-960 | http://www.glycoepitope.jp/epitopes/EP0048 | denotes | GM1b |
| T3 | 994-998 | http://www.glycoepitope.jp/epitopes/EP0048 | denotes | GM1b |
| T4 | 1126-1130 | http://www.glycoepitope.jp/epitopes/EP0056 | denotes | GD1a |
sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| TextSentencer_T1 | 0-163 | Sentence | denotes | The ganglioside GD1 alpha' IV3Neu5Ac, III6Neu5Ac-GgOse4Cer, is a major disialoganglioside in the highly metastatic murine lymphoreticular tumour cell line MDAY-D2. |
| TextSentencer_T2 | 164-312 | Sentence | denotes | The aim of the present study was to investigate the ganglioside expression of the highly metastatic murine lymphoreticular tumour cell line MDAY-D2. |
| TextSentencer_T3 | 313-453 | Sentence | denotes | Cells were propagated under controlled pH conditions and oxygen supply in bioreactors of 1 and 7.5 l volumes by repeated batch fermentation. |
| TextSentencer_T4 | 454-676 | Sentence | denotes | Gangliosides were isolated from 2.7 x 10(11) cells, purified by silica gel chromatography and separated into mono- and disialoganglioside fractions by preparative DEAE anion exchange high performance liquid chromatography. |
| TextSentencer_T5 | 677-756 | Sentence | denotes | Individual gangliosides were obtained by preparative thin layer chromatography. |
| TextSentencer_T6 | 757-882 | Sentence | denotes | Their structural features were established by immunostaining, fast atom bombardment and gas chromatography mass spectrometry. |
| TextSentencer_T7 | 883-1164 | Sentence | denotes | In addition to gangliosides of the GM1a-pathway (GM2, GM1a and GD1a) and GM1b (IV3Neu5Ac-GgOse4Cer) and GalNAc-GM1b of the Gm1b-pathway, the disialoganglioside GD1 alpha (IV3Neu5Ac, III6Neu5Ac-GgOse4Cer) was found in equal amounts compared to GD1a (IV3Neu5Ac, II3Neu5Ac-GgOse4Cer). |
| TextSentencer_T8 | 1165-1303 | Sentence | denotes | All gangliosides were substituted with C24:0, 24:1 and C16:0 fatty acids, sphingosine and N-acetylneuraminic acid as the sole sialic acid. |
| T1 | 0-163 | Sentence | denotes | The ganglioside GD1 alpha' IV3Neu5Ac, III6Neu5Ac-GgOse4Cer, is a major disialoganglioside in the highly metastatic murine lymphoreticular tumour cell line MDAY-D2. |
| T2 | 164-312 | Sentence | denotes | The aim of the present study was to investigate the ganglioside expression of the highly metastatic murine lymphoreticular tumour cell line MDAY-D2. |
| T3 | 313-453 | Sentence | denotes | Cells were propagated under controlled pH conditions and oxygen supply in bioreactors of 1 and 7.5 l volumes by repeated batch fermentation. |
| T4 | 454-676 | Sentence | denotes | Gangliosides were isolated from 2.7 x 10(11) cells, purified by silica gel chromatography and separated into mono- and disialoganglioside fractions by preparative DEAE anion exchange high performance liquid chromatography. |
| T5 | 677-756 | Sentence | denotes | Individual gangliosides were obtained by preparative thin layer chromatography. |
| T6 | 757-882 | Sentence | denotes | Their structural features were established by immunostaining, fast atom bombardment and gas chromatography mass spectrometry. |
| T7 | 883-1164 | Sentence | denotes | In addition to gangliosides of the GM1a-pathway (GM2, GM1a and GD1a) and GM1b (IV3Neu5Ac-GgOse4Cer) and GalNAc-GM1b of the Gm1b-pathway, the disialoganglioside GD1 alpha (IV3Neu5Ac, III6Neu5Ac-GgOse4Cer) was found in equal amounts compared to GD1a (IV3Neu5Ac, II3Neu5Ac-GgOse4Cer). |
| T8 | 1165-1303 | Sentence | denotes | All gangliosides were substituted with C24:0, 24:1 and C16:0 fatty acids, sphingosine and N-acetylneuraminic acid as the sole sialic acid. |
GlyCosmos6-Glycan-Motif-Structure
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 16-19 | https://glytoucan.org/Structures/Glycans/G24638PB | denotes | GD1 |
| T2 | 16-19 | https://glytoucan.org/Structures/Glycans/G81983KG | denotes | GD1 |
| T3 | 932-935 | https://glytoucan.org/Structures/Glycans/G61168WC | denotes | GM2 |
| T4 | 932-935 | https://glytoucan.org/Structures/Glycans/G79389NT | denotes | GM2 |
| T5 | 946-950 | https://glytoucan.org/Structures/Glycans/G46677TE | denotes | GD1a |
| T6 | 946-950 | https://glytoucan.org/Structures/Glycans/G69277LC | denotes | GD1a |
| T7 | 956-960 | https://glytoucan.org/Structures/Glycans/G03277YI | denotes | GM1b |
| T8 | 994-998 | https://glytoucan.org/Structures/Glycans/G03277YI | denotes | GM1b |
| T9 | 1006-1010 | https://glytoucan.org/Structures/Glycans/G03277YI | denotes | Gm1b |
| T10 | 1043-1046 | https://glytoucan.org/Structures/Glycans/G24638PB | denotes | GD1 |
| T11 | 1043-1046 | https://glytoucan.org/Structures/Glycans/G81983KG | denotes | GD1 |
| T12 | 1126-1130 | https://glytoucan.org/Structures/Glycans/G46677TE | denotes | GD1a |
| T13 | 1126-1130 | https://glytoucan.org/Structures/Glycans/G69277LC | denotes | GD1a |
| T14 | 1255-1278 | https://glytoucan.org/Structures/Glycans/G50850NI | denotes | N-acetylneuraminic acid |
| T15 | 1255-1278 | https://glytoucan.org/Structures/Glycans/G81533KY | denotes | N-acetylneuraminic acid |
| T16 | 1291-1302 | https://glytoucan.org/Structures/Glycans/G81533KY | denotes | sialic acid |
HP-phenotype
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T1 | 138-144 | Phenotype | denotes | tumour | HP:0002664 |
| T2 | 287-293 | Phenotype | denotes | tumour | HP:0002664 |
Glycan-GlyCosmos
| Id | Subject | Object | Predicate | Lexical cue | image |
|---|---|---|---|---|---|
| T1 | 16-25 | Glycan | denotes | GD1 alpha | https://api.glycosmos.org/wurcs2image/latest/png/binary/G07394RV |
| T2 | 918-922 | Glycan | denotes | GM1a | https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR |
| T3 | 932-935 | Glycan | denotes | GM2 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G79389NT |
| T4 | 937-941 | Glycan | denotes | GM1a | https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR |
| T5 | 946-950 | Glycan | denotes | GD1a | https://api.glycosmos.org/wurcs2image/latest/png/binary/G46677TE |
| T6 | 956-960 | Glycan | denotes | GM1b | https://api.glycosmos.org/wurcs2image/latest/png/binary/G03277YI |
| T7 | 987-993 | Glycan | denotes | GalNAc | https://api.glycosmos.org/wurcs2image/latest/png/binary/G39738WL |
| T8 | 994-998 | Glycan | denotes | GM1b | https://api.glycosmos.org/wurcs2image/latest/png/binary/G03277YI |
| T9 | 1043-1052 | Glycan | denotes | GD1 alpha | https://api.glycosmos.org/wurcs2image/latest/png/binary/G07394RV |
| T10 | 1126-1130 | Glycan | denotes | GD1a | https://api.glycosmos.org/wurcs2image/latest/png/binary/G46677TE |
GlyCosmos15-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T1 | 138-144 | Phenotype | denotes | tumour | HP:0002664 |
| T2 | 287-293 | Phenotype | denotes | tumour | HP:0002664 |
GlyCosmos15-CL
| Id | Subject | Object | Predicate | Lexical cue | cl_id |
|---|---|---|---|---|---|
| T1 | 138-149 | Cell | denotes | tumour cell | http://purl.obolibrary.org/obo/CL:0001063 |
| T2 | 287-298 | Cell | denotes | tumour cell | http://purl.obolibrary.org/obo/CL:0001063 |
GlyCosmos15-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T1 | 122-137 | Body_part | denotes | lymphoreticular | http://purl.obolibrary.org/obo/UBERON_0000363 |
| T2 | 271-286 | Body_part | denotes | lymphoreticular | http://purl.obolibrary.org/obo/UBERON_0000363 |
| T3 | 735-740 | Body_part | denotes | layer | http://purl.obolibrary.org/obo/UBERON_0000119|http://purl.obolibrary.org/obo/UBERON_0022303 |
| T5 | 1286-1290 | Body_part | denotes | sole | http://purl.obolibrary.org/obo/UBERON_0008338 |
sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| TextSentencer_T1 | 0-163 | Sentence | denotes | The ganglioside GD1 alpha' IV3Neu5Ac, III6Neu5Ac-GgOse4Cer, is a major disialoganglioside in the highly metastatic murine lymphoreticular tumour cell line MDAY-D2. |
| TextSentencer_T2 | 164-312 | Sentence | denotes | The aim of the present study was to investigate the ganglioside expression of the highly metastatic murine lymphoreticular tumour cell line MDAY-D2. |
| TextSentencer_T3 | 313-453 | Sentence | denotes | Cells were propagated under controlled pH conditions and oxygen supply in bioreactors of 1 and 7.5 l volumes by repeated batch fermentation. |
| TextSentencer_T4 | 454-676 | Sentence | denotes | Gangliosides were isolated from 2.7 x 10(11) cells, purified by silica gel chromatography and separated into mono- and disialoganglioside fractions by preparative DEAE anion exchange high performance liquid chromatography. |
| TextSentencer_T5 | 677-756 | Sentence | denotes | Individual gangliosides were obtained by preparative thin layer chromatography. |
| TextSentencer_T6 | 757-882 | Sentence | denotes | Their structural features were established by immunostaining, fast atom bombardment and gas chromatography mass spectrometry. |
| TextSentencer_T7 | 883-1164 | Sentence | denotes | In addition to gangliosides of the GM1a-pathway (GM2, GM1a and GD1a) and GM1b (IV3Neu5Ac-GgOse4Cer) and GalNAc-GM1b of the Gm1b-pathway, the disialoganglioside GD1 alpha (IV3Neu5Ac, III6Neu5Ac-GgOse4Cer) was found in equal amounts compared to GD1a (IV3Neu5Ac, II3Neu5Ac-GgOse4Cer). |
| TextSentencer_T8 | 1165-1303 | Sentence | denotes | All gangliosides were substituted with C24:0, 24:1 and C16:0 fatty acids, sphingosine and N-acetylneuraminic acid as the sole sialic acid. |
| T1 | 0-163 | Sentence | denotes | The ganglioside GD1 alpha' IV3Neu5Ac, III6Neu5Ac-GgOse4Cer, is a major disialoganglioside in the highly metastatic murine lymphoreticular tumour cell line MDAY-D2. |
| T2 | 164-312 | Sentence | denotes | The aim of the present study was to investigate the ganglioside expression of the highly metastatic murine lymphoreticular tumour cell line MDAY-D2. |
| T3 | 313-453 | Sentence | denotes | Cells were propagated under controlled pH conditions and oxygen supply in bioreactors of 1 and 7.5 l volumes by repeated batch fermentation. |
| T4 | 454-676 | Sentence | denotes | Gangliosides were isolated from 2.7 x 10(11) cells, purified by silica gel chromatography and separated into mono- and disialoganglioside fractions by preparative DEAE anion exchange high performance liquid chromatography. |
| T5 | 677-756 | Sentence | denotes | Individual gangliosides were obtained by preparative thin layer chromatography. |
| T6 | 757-882 | Sentence | denotes | Their structural features were established by immunostaining, fast atom bombardment and gas chromatography mass spectrometry. |
| T7 | 883-1164 | Sentence | denotes | In addition to gangliosides of the GM1a-pathway (GM2, GM1a and GD1a) and GM1b (IV3Neu5Ac-GgOse4Cer) and GalNAc-GM1b of the Gm1b-pathway, the disialoganglioside GD1 alpha (IV3Neu5Ac, III6Neu5Ac-GgOse4Cer) was found in equal amounts compared to GD1a (IV3Neu5Ac, II3Neu5Ac-GgOse4Cer). |
| T8 | 1165-1303 | Sentence | denotes | All gangliosides were substituted with C24:0, 24:1 and C16:0 fatty acids, sphingosine and N-acetylneuraminic acid as the sole sialic acid. |
GlyCosmos15-Sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-163 | Sentence | denotes | The ganglioside GD1 alpha' IV3Neu5Ac, III6Neu5Ac-GgOse4Cer, is a major disialoganglioside in the highly metastatic murine lymphoreticular tumour cell line MDAY-D2. |
| T2 | 164-312 | Sentence | denotes | The aim of the present study was to investigate the ganglioside expression of the highly metastatic murine lymphoreticular tumour cell line MDAY-D2. |
| T3 | 313-453 | Sentence | denotes | Cells were propagated under controlled pH conditions and oxygen supply in bioreactors of 1 and 7.5 l volumes by repeated batch fermentation. |
| T4 | 454-676 | Sentence | denotes | Gangliosides were isolated from 2.7 x 10(11) cells, purified by silica gel chromatography and separated into mono- and disialoganglioside fractions by preparative DEAE anion exchange high performance liquid chromatography. |
| T5 | 677-756 | Sentence | denotes | Individual gangliosides were obtained by preparative thin layer chromatography. |
| T6 | 757-882 | Sentence | denotes | Their structural features were established by immunostaining, fast atom bombardment and gas chromatography mass spectrometry. |
| T7 | 883-1164 | Sentence | denotes | In addition to gangliosides of the GM1a-pathway (GM2, GM1a and GD1a) and GM1b (IV3Neu5Ac-GgOse4Cer) and GalNAc-GM1b of the Gm1b-pathway, the disialoganglioside GD1 alpha (IV3Neu5Ac, III6Neu5Ac-GgOse4Cer) was found in equal amounts compared to GD1a (IV3Neu5Ac, II3Neu5Ac-GgOse4Cer). |
| T8 | 1165-1303 | Sentence | denotes | All gangliosides were substituted with C24:0, 24:1 and C16:0 fatty acids, sphingosine and N-acetylneuraminic acid as the sole sialic acid. |
GlyCosmos15-Glycan
| Id | Subject | Object | Predicate | Lexical cue | image |
|---|---|---|---|---|---|
| T1 | 16-25 | Glycan | denotes | GD1 alpha | https://api.glycosmos.org/wurcs2image/latest/png/binary/G07394RV |
| T2 | 918-922 | Glycan | denotes | GM1a | https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR |
| T3 | 932-935 | Glycan | denotes | GM2 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G79389NT |
| T4 | 937-941 | Glycan | denotes | GM1a | https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR |
| T5 | 946-950 | Glycan | denotes | GD1a | https://api.glycosmos.org/wurcs2image/latest/png/binary/G46677TE |
| T6 | 956-960 | Glycan | denotes | GM1b | https://api.glycosmos.org/wurcs2image/latest/png/binary/G03277YI |
| T7 | 987-993 | Glycan | denotes | GalNAc | https://api.glycosmos.org/wurcs2image/latest/png/binary/G39738WL |
| T8 | 994-998 | Glycan | denotes | GM1b | https://api.glycosmos.org/wurcs2image/latest/png/binary/G03277YI |
| T9 | 1043-1052 | Glycan | denotes | GD1 alpha | https://api.glycosmos.org/wurcs2image/latest/png/binary/G07394RV |
| T10 | 1126-1130 | Glycan | denotes | GD1a | https://api.glycosmos.org/wurcs2image/latest/png/binary/G46677TE |
GlyCosmos15-GlycoEpitope
| Id | Subject | Object | Predicate | Lexical cue | glycoepitope_id |
|---|---|---|---|---|---|
| T1 | 946-950 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GD1a | http://www.glycoepitope.jp/epitopes/EP0056 |
| T2 | 956-960 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GM1b | http://www.glycoepitope.jp/epitopes/EP0048 |
| T3 | 994-998 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GM1b | http://www.glycoepitope.jp/epitopes/EP0048 |
| T4 | 1126-1130 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GD1a | http://www.glycoepitope.jp/epitopes/EP0056 |
GlyCosmos15-Lectin-Jamboree
| Id | Subject | Object | Predicate | Lexical cue | glycosmos_id |
|---|---|---|---|---|---|
| T1 | 1220-1223 | Lectin | denotes | C16 | GL_005239 |
GlyCosmos-GlycoEpitope
| Id | Subject | Object | Predicate | Lexical cue | glycoepitope_id |
|---|---|---|---|---|---|
| T1 | 946-950 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GD1a | http://www.glycoepitope.jp/epitopes/EP0056 |
| T2 | 956-960 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GM1b | http://www.glycoepitope.jp/epitopes/EP0048 |
| T3 | 994-998 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GM1b | http://www.glycoepitope.jp/epitopes/EP0048 |
| T4 | 1126-1130 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GD1a | http://www.glycoepitope.jp/epitopes/EP0056 |
Anatomy-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T1 | 122-137 | Body_part | denotes | lymphoreticular | http://purl.obolibrary.org/obo/UBERON_0000363 |
| T2 | 271-286 | Body_part | denotes | lymphoreticular | http://purl.obolibrary.org/obo/UBERON_0000363 |
| T3 | 735-740 | Body_part | denotes | layer | http://purl.obolibrary.org/obo/UBERON_0000119|http://purl.obolibrary.org/obo/UBERON_0022303 |
| T5 | 1286-1290 | Body_part | denotes | sole | http://purl.obolibrary.org/obo/UBERON_0008338 |